Related Experiment Videos
Idiopathic juvenile osteoporosis
1Department of Endocrinology and Metabolism, Panagia General Hospital, Thessaloniki, Greece. krassas@the.forthnet.gr
Annals of the New York Academy of Sciences
|May 20, 2000
Summary
Idiopathic juvenile osteoporosis (IJO) is a rare childhood condition with unknown causes, diagnosed by excluding other diseases. Treatment focuses on spinal protection, with therapies showing equivocal results as the condition typically resolves spontaneously.
Area of Science:
- Pediatrics
- Endocrinology
- Bone Metabolism
Background:
- Osteoporosis in children is rare and often secondary to other conditions.
- Idiopathic juvenile osteoporosis (IJO) is diagnosed when other causes are excluded, characterized by unknown etiology and bone fractures.
- Congenital conditions like osteogenesis imperfecta can also present with childhood osteoporosis.
Purpose of the Study:
- To review the characteristics and management of idiopathic juvenile osteoporosis (IJO).
- To highlight diagnostic criteria and treatment strategies for pediatric osteoporosis.
- To discuss the natural course and prognosis of IJO.
Main Methods:
- Diagnosis relies on excluding secondary causes of osteoporosis.
- Evaluation involves assessing bone fractures and overall health status.
- Literature review on existing therapeutic interventions for IJO.
Main Results:
- The etiology of IJO remains unknown.
- Treatment strategies include spinal protection, with sex steroids being contraindicated.
- Administered therapies like bisphosphonates, calcitriol, fluoride, and calcitonin yielded equivocal results.
- The condition typically undergoes spontaneous remission.
Conclusions:
- Idiopathic juvenile osteoporosis (IJO) is a diagnosis of exclusion in pediatric patients.
- Current treatments for IJO have limited efficacy, and management focuses on supportive care.
- The disease usually resolves on its own, emphasizing the importance of monitoring and protection.